MMVIP featured in LexisNexis PatentAdvisor® Case Study
One of our Partners, C.G. Moore, has been featured in and contributed to a case study for LexisNexis PatentAdvisor®, a…
One of our Partners, C.G. Moore, has been featured in and contributed to a case study for LexisNexis PatentAdvisor®, a…
Life sciences patent practitioners know that written description rejections under 35 U.S.C. § 112 for genus claims nearly always refer…
The USPTO examiners use the broadest reasonable interpretation (BRI) when construing claims during examination of patent applications. The BRI standard…
The USPTO encourages Applicants to engage with Patent Examiners using Interview Practice. According to the USPTO website, “Interviews provide an…
Previously, we wrote about making an application special to speed up patent prosecution based on an inventor’s age. 37 CFR…
The USPTO has announced that the After Final Consideration Pilot (AFCP) 2.0 program will be extended until September 30, 2020. This…